Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 417

Results For "IT"

10475 News Found

Indian Pharmacopoeia 2026 highlights need for stronger drug standards and global alignment
Policy | April 18, 2026

Indian Pharmacopoeia 2026 highlights need for stronger drug standards and global alignment

Experts highlighted that robust pharmacopoeial frameworks are essential for maintaining the quality, safety and efficacy of medicines


Department of Pharmaceuticals seeks proposals for SPEL study to strengthen logistics ecosystem
Supply Chain | April 18, 2026

Department of Pharmaceuticals seeks proposals for SPEL study to strengthen logistics ecosystem

Bidding window open till May 15; study to map costs and bottlenecks across pharma supply chains


Piramal Pharma, Ajinomoto Bio-Pharma collaborate to accelerate ADC development
Biopharma | April 17, 2026

Piramal Pharma, Ajinomoto Bio-Pharma collaborate to accelerate ADC development

Collaboration integrates AJICAP™ technology with global manufacturing capabilities to streamline antibody-drug conjugate pipelines


NIFTY Pharma shows stable trend amid cautious market sentiment
News | April 17, 2026

NIFTY Pharma shows stable trend amid cautious market sentiment

Muted movement reflects consolidation phase as investors await earnings triggers


Morepen Laboratories secures fourth consecutive USFDA ‘NIL 483’ inspection
Drug Approval | April 17, 2026

Morepen Laboratories secures fourth consecutive USFDA ‘NIL 483’ inspection

Zero-observation outcomes strengthen global credibility and accelerate CDMO ambitions


Salve Group launches Parasoft foot cream to address dry and cracked feet
News | April 17, 2026

Salve Group launches Parasoft foot cream to address dry and cracked feet

This combination works to break down rough patches, improve moisture retention, and enhance overall skin texture


Syntegon reports record FY25 Results; revenue rises 10% to €1.75 billion
Supply Chain | April 17, 2026

Syntegon reports record FY25 Results; revenue rises 10% to €1.75 billion

The company allocated €56 million to research and development for next-generation line solutions


Bayer flags major Phase III results for stroke prevention drug asundexian
Clinical Trials | April 17, 2026

Bayer flags major Phase III results for stroke prevention drug asundexian

The study evaluated asundexian (50 mg), a once-daily oral anticoagulant candidate, versus placebo—both given alongside standard antiplatelet therapy


DKSH and Sanofi join forces to expand access to cardio & diabetes treatments in Southeast Asia
Supply Chain | April 17, 2026

DKSH and Sanofi join forces to expand access to cardio & diabetes treatments in Southeast Asia

The aim is to bolster healthcare delivery in a region increasingly burdened by chronic disease


OpenAI unveils GPT-Rosalind to accelerate drug discovery for pharma giants
Digitisation | April 17, 2026

OpenAI unveils GPT-Rosalind to accelerate drug discovery for pharma giants

New purpose-built AI model targets faster R&D cycles and deeper scientific insights across life sciences